Evidence map›Paper›PMID 27055402›Full record

ArticleCell biology and toxicology2016

Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.

Kevin M Poindexter, Susanne Matthew, Ida Aronchik, Gary L Firestone

Open access · greenAbstract read
In one paragraph

Article in Cell biology and toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin M PoindexterDepartment of Molecular and Cell Biology and The Cancer Research Laboratory, University of California at Berkeley, 591 LSA, Berkeley, CA, 94720-3200, USA.
Susanne MatthewDepartment of Molecular and Cell Biology and The Cancer Research Laboratory, University of California at Berkeley, 591 LSA, Berkeley, CA, 94720-3200, USA.
Ida AronchikDepartment of Molecular and Cell Biology and The Cancer Research Laboratory, University of California at Berkeley, 591 LSA, Berkeley, CA, 94720-3200, USA.
Gary L FirestoneDepartment of Molecular and Cell Biology and The Cancer Research Laboratory, University of California at Berkeley, 591 LSA, Berkeley, CA, 94720-3200, USA. glfire@berkeley.edu.
University of California, Berkeley · US

Funding

Indolecarbinol target proteins and anti-cancer signaling in human melanoma cellsR01CA164095 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI FIRESTONE, GARY L · 2012 to 2015
$862k
NCI NIH HHS R01 CA164095
6 · The paper itself

Abstract

Antiproliferative signaling of combinations of the nonsteroidal anti-inflammatory drug acetylsalicylic acid (aspirin) and indole-3-carbinol (I3C), a natural indolecarbinol compound derived from cruciferous vegetables, was investigated in human melanoma cells. Melanoma cell lines with distinct mutational profiles were sensitive to different extents to the antiproliferative response of aspirin, with oncogenic BRAF-expressing G361 cells and wild-type BRAF-expressing SK-MEL-30 cells being the most responsive. I3C triggered a strong proliferative arrest of G361 melanoma cells and caused only a modest decrease in the proliferation of SK-MEL-30 cells. In both cell lines, combinations of aspirin and I3C cooperatively arrested cell proliferation and induced a G1 cell cycle arrest, and nearly ablated protein and transcript levels of the melanocyte master regulator microphthalmia-associated transcription factor isoform M (MITF-M). In melanoma cells transfected with a -333/+120-bp MITF-M promoter-luciferase reporter plasmid, treatment with aspirin and I3C cooperatively disrupted MITF-M promoter activity, which accounted for the loss of MITF-M gene products. Mutational analysis revealed that the aspirin required the LEF1 binding site, whereas I3C required the BRN2 binding site to mediate their combined and individual effects on MITF-M promoter activity. Consistent with LEF1 being a downstream effector of Wnt signaling, aspirin, but not I3C, downregulated protein levels of the Wnt co-receptor LDL receptor-related protein-6 and β-catenin and upregulated the β-catenin destruction complex component Axin. Taken together, our results demonstrate that aspirin-regulated Wnt signaling and I3C-targeted signaling pathways converge at distinct DNA elements in the MITF-M promoter to cooperatively disrupt MITF-M expression and melanoma cell proliferation.

Indexed as

AspirinCell CycleCell Line, TumorCell ProliferationDown-RegulationDrug SynergismGene ExpressionHumansIndolesMelanomaMicrophthalmia-Associated Transcription FactorPromoter Regions, GeneticSignal TransductionWnt Signaling PathwayAspirinindole-3-carbinolIndolesMicrophthalmia-Associated Transcription FactorMITF protein, humanAspirinIndole-3-carbinolLEF1Melanoma cellsMicrophthalmia-associated transcription factorWnt signaling

Identifiers

PMID27055402
PMCPMC4905717
OpenAlexW2327750609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.